Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly…
Read More
Novo and Eli contender Zealand Pharma heralds its obesity drug alternative: It’s our ‘crown jewel’
Byadmin
Oct 11, 2024